Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome

Critical Care Medicine

Volumn 24, Issue 8, 1996, Pages 1285-1292

  Schwartz, Michael D ^a   Moore, Ernest E ^a   Moore, Frederick A ^a   Shenkar, Robert ^a   Moine, Pierre ^a   Haenel, James B ^a   Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

acute lung injury; ARDS; cytokines; interleukins; nuclear factor B; oxygen radicals; sepsis; shock; transcriptional factors; trauma

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NUCLEAR FACTOR; NUCLEAR PROTEIN; PLASMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN CELL; INJURY SCALE; INTENSIVE CARE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029787027     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199608000-00004     Document Type: Article

References (75)

1. Kolleff MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37
2. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339:466-469
3. Bernard GR, Artigas A, Brigham KL, et al: The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
4. Hudson LD, Milberg JA, Anardi D, et al: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 293-301
5. Pepe PE, Potkin RT, Reus DH, et al: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982; 144:124-130
6. Donnelly TJ, Meade P, Jagels M, et al: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome following severe injury. Crit Care Med 1994; 22:768-776
7. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-647
8. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427-432
9. Chollet-Martin S, Montravers P, Gilbert C, et al: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993; 61:4553-4559
10. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar level of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with the adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145: 1016-1022
11. Millar AB, Foley NM, Singer M, et al: Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989; ii:712-714
12. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the bronchoalveolar lavage of patients with ARDS: Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-1314
13. Baeuerle PA: The inducible transcription factor NF-κB: Regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072:63-80
14. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179
15. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12:2005-2015
16. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10:2247-2258
17. Tanabe O, Akira S, Kamiya T, et al: Genomic structure of the murine IL-6 gene: High degree conservation of potential regulatory sequences between mouse and human. J Immunol 1988; 141:3875-3881
18. Roesler WJ, Vandenbark GR, Hanson RW: Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 1988; 263:9063-9066
19. Lee KAW, Masson N: Transcriptional regulation by CREB and its relatives. Biochim Biophys Acta 1993; 1174: 221-233
20. Lee W, Mitchell P, Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 1987; 49:741-752
21. Briggs MR, Kadonaga JT, Bell SP, et al: Purification and biochemical characterization of the promoter-specific transcription factor, SP-1. Science 1986; 234: 47-52
22. Trede NS, Geha RS, Chatila T: Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands. J Immunol 1991; 146: 2310-2315
23. Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor-α transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 1990; 10:1498-1506
24. Liberman TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 1990; 10:2327-2334
25. Shenkar R, Abraham E: Plasma from hemorrhaged mice activates CREB and increases cytokine expression in lung mononuclear cells through a xanthine-oxidase dependent mechanism. Am J Respir Cell Mol Biol 1996; 14:198-206
26. Grilli M, Chiu JJS, Lenardo MJ: NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143:1-62
27. Godambe SA, Chaplin DD, Takova T, et al: An NF-IL6 sequence near the transcriptional initiation site is necessary for the lipopolysaccharide induction of murine interleukin-1β. DNA Cell Biol 1994; 13:561-569
28. Pahl HL, Baeuerle PA: Oxygen and the control of gene expression. Bioessays 1994; 16:497-502
29. Newell C, Deisseroth A, Lopez-Berestein G: Analysis of complexes binding to the TNF promoter. Abstr. Proc Annu Meet Am Assoc Cancer Res 1993; 34:A2666
30. Pope RM, Leutz A, Ness SA: C/EBPβ regulation of the tumor necrosis factor-α gene. J Clin Invest 1994; 94:1449-1455
31. Chrivia JC, Kwok RPS, Lamp N, et al: Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365:855-859
32. Matsusaka T, Fujikawa K, Nishio Y, et al: Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8. Proc Natl Acad Sci U S A 1993; 90:10193-10197
33. Zhang Y, Broser M: Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB. Proc Natl Acad Sci U S A 1994; 91:2225-2229
34. Stein B, Baldwin AS: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperatively between C/EBP and NF-κB. Mol Cell Biol 1993; 13:7191-7198
35. Abraham E: Alterations in transcriptional regulation of proinflammatory and immunoregulatory cytokine expression by hemorrhage, injury, and critical illness. New Horiz 1996; 4:184-193
36. Steinberg KP, Mitchell DR, Maunder RJ, et al: Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148:556-561
37. Montravers P, Gauzit R, Dombret MC, et al: Cardiopulmonary effects of bronchoalveolar lavage in critically ill patients. Chest 1993; 104:1541-1547
38. Papazian L, Colt HG, Scemama F, et al: Effects of consecutive protected specimen brushing and bronchoalveolar lavage on gas exchange and hemodynamics in ventilated patients. Chest 1993; 104:1548-1552
39. Hertz MI: Minimizing the risk of bronchoscopy during mechanical ventilation. Chest 1993; 104:1319-1320
40. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
41. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
42. Baker SP, O'Neill B, Long WB: The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14:187-196
43. McAnena OJ, Moore FA, Moore EE, et al: Invalidation of the APACHE II scoring system for patients with acute trauma. J Trauma 1992; 33:504-507
44. Chelen CJ, Fang Y, Freeman GJ, et al: Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995; 95: 1415-1421
45. Shenkar R, Schwartz MD, Terada LS, et al: Hemorrhage activates NF-κB in murine lung mononuclear cells in vivo. Am J Physiol, In Press
46. Dignam JD, Martin PL, Shatry BS, et al: Eukaryotic gene transcription with purified components. Methods Enzymol 1983; 101:582-598
47. Qian J, Bours V, Manischewitz J, et al: Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-κB DNA binding proteins. J Immunol 1994; 152:4183-4191
48. Schwartz MD, Repine JE, Abraham E: Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 1995; 12: 434-440
49. 2+ dependence, and differential half-site recognition. J Biol Chem 1991; 266:252-260
50. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ, Erlbaum Associates, 1988
51. Brown BW, Hollander M: Statistics: A Biomedical Introduction. New York, John Wiley & Sons, 1977
52. Thieblemont N, Haeffner-Cavaillon N, Haeffner A, et al: Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-κB (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells. J Immunol 1995; 155:4861-4867
53. Blake DR, Winyard PG, Marok R: The contribution of hypoxia-reperfusion injury to inflammatory synovitis: The influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann N Y Acad Sci 1994; 723:308-317
54. Machleidt T, Wiegmann K, Henkel T, et al: Sphingomyelinase activates proteolytic IκB-α degradation in a cell-free system. J Biol Chem 1994; 269:13760-13765
55. Yang Z, Costanzo M, Golde DW, et al: Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J Biol Chem 1993; 268:20520-20523
56. Raines MA, Kolesnick RN, Golde DW: Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993; 268:14572-14575
57. Sen R, Baltimore D: Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 1986; 47:921-928
58. Eugui EM, Delustro B, Rouhafza S, et al: Some antioxidants inhibit, in a coordinate fashion, the production of tumor necrosis factor-α, IL-β, and IL-6, by human peripheral blood mononuclear cells. Int Immunol 1994; 6:409-422
59. Hoch RC, Rodriguez R, Manning T, et al: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845
60. Meade P, Shoemaker WC, Donnelly TJ, et al: Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 1994; 36:651-657
61. Endo S, Inada K, Yamada Y, et al: Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 1994; 22:949-955
62. Moore FA, Moore EE, Pogetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 1991; 31:629-638
63. Wright SD, Kolesnick RN: Does endotoxin stimulate cells by mimicking ceramide? Immunol Today 1995; 16: 297-302
64. Ghosh S, Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 1990; 344:678-682
65. Read MA, Whitley MZ, Williams AJ, et al: NF-κB and IκBa: An inducible regulatory system in endothelial activation. J Exp Med 1994; 179:503-512
66. Henkel T, Machleidt T, Alkalay I, et al: Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 1993; 365:182-185
67. Thompson JE, Phillips RJ, Erdjument-Bromage H, et al: IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 1995; 80:573-582
68. Thanos D, Maniatis T: NF-κB: A lesson in family values. Cell 1995; 80:529-532
69. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994; 265:956-959
70. Auphan N, DiDonato JA, Rosette C, et al: Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270:286-290
71. Scheinman RI, Cogswell PC, Lofquist AK, et al: Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283-286
72. Inoue J, Takahara T, Akizawa T, et al: Bcl-3, a member of the IκB proteins, has distinct specificity towards the Rel family of proteins. Oncogens 1993; 8: 2067-2073
73. Wulczyn FG, Naumann M, Scheidereit C: Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 1992; 358:597-599
74. Naumann M, Wulczyn FG, Scheidereit C: The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J 1993; 12:213-222
75. Lenardo M, Siebenlist U: Bcl-3 mediated nuclear regulation of the NF-κB trans-activating factor. Immunol Today 1994; 15:145-147